Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Protein Kinase A
More Information »Protein kinase A (PKA, aka cAMP-dependent protein kinase) is involved in the regulation of lipid and glucose metabolism and is a component of the signal transduction mechanism of certain GPCRs. PKA is composed of two regulatory subunits and two catalytic subunits.
Protein Kinase A Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 1337 | cAMPS-Rp, triethylammonium salt |
| cAMP antagonist; inhibits PKA activation | |
| 0541 | Fasudil hydrochloride |
| Inhibitor of cyclic nucleotide dependent- and Rho-kinases | |
| 1883 | cGMP Dependent Kinase Inhibitor Peptide |
| Inhibitor of protein kinases G and A | |
| 2910 | H 89 dihydrochloride |
| Protein kinase A inhibitor | |
| 1288 | KT 5720 |
| Selective protein kinase A inhibitor | |
| 1904 | PKA inhibitor fragment (6-22) amide |
| Potent protein kinase A inhibitor | |
| 2546 | PKI 14-22 amide, myristoylated |
| Cell-permeable protein kinase A inhibitor | |
Activators |
|
Cat.No. |
Product Name / Activity |
| 1333 | cAMPS-Sp, triethylammonium salt |
| Cell-permeable cAMP analog; activates PKA | |
| 1140 | 8-Bromo-cAMP, sodium salt |
| Membrane permeable cAMP analog; activates PKA | |
Ligand Sets |
|
Cat.No. |
Product Name / Activity |
| 1882 | PKA Tocriset™ |
| Selection of 5 PKA modulators (Cat. Nos. 1337, 1140, 1099, 1288 and 1603) | |
Related Categories
Quick Order
Find multiple products by catalog number
Tocris Events
Win a Kindle
5th Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders
June 23 - 26, 2013
Bath, UK





